Uroxate
Uroxate
Urinary Tract Spasmolytic

UROXATE

Flavoxate is an anticholinergic with anti-muscarinic effects. Its muscle relaxant properties may be due to a direct action on smooth muscle rather than by antagonizing muscarinic receptors.

barcode

When you want relief, always choose the best….

UROXATE

Generic Name:                   Flavoxate HCl

Therapeutic Category:    Urinary tract spasmolytic

Pharmacological Class:   Phosphodiesterase inhibitor

Composition:                      Each film coated tablet contains Flavoxate HCl BP 200 mg.

Pregnancy Category:       B

Presentation:                      Available in the pack size as 10 tablets X 10 blisters

Mechanism of Action

UROXATE exerts a direct relaxant effect on smooth muscles via phosphodiesterase inhibition, providing relief to a variety of smooth muscle spasms. This counteracts smooth muscle spasms of urinary tract.

Indications

  • Urinary frequency & incontinence*
  • Cytoscopy*/surgery
  • Urethrocystitis*/urethrotrigonitis*
  • Bladder spasms due to catheterisation
  • Urinary urgency
  • Symptomatic relief of dysuria
  • Nocturia*
  • Cystitis 
  • Urethritis
  • Suprapubic* pain
  • Dysuria
  • Prostatitis

Dosage

Route of administration: Oral

Children <12 years: Not recommended; safety and efficacy not established

Children ≥12 years: 100-200 mg PO q6-8hr

18 years and older: 200 mg orally 3 to 4 times daily

Medication to be taken after meals. 

Pharmacokinetics                                                                                      

Absorption: Well absorbed from gastrointestinal tract.

Protein binding: Approximately 90%

Metabolism: Hepatic (rapid metabolism)

Route of elimination: Urine (50-60%)

Half-life: 2-3 minutes

 

Adverse Effects

UROXATE is generally well tolerated, but can potentially cause, vomiting, upset stomach, dry mouth or throat, blurred vision, eye pain, and increased sensitivity of your eyes to light.

Contraindications

UROXATE is contraindicated in the following conditions:

  • Obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastro-intestinal hemorrhage and obstructive uropathies of the lower urinary tract.
  • Hypersensitivity to Flavoxate hydrochloride or to any of the excipients of Uroxate.

Precautions

UROXATE must be used cautiously in:

  • Patients with suspected glaucoma, especially closed angle cases

Interactions

Scroll: Horizontal: *Terminologies:
Incontinence: Lack of voluntary control over urination or defecation.
Cystoscopy: Procedure that allows your doctor to examine the lining of your bladder and the tube that carries urine out of your body (urethra)
Urethrocystitis/Urethrotrigonitis: Inflammation of the urethra and the bladder; trigone of the bladder
Nocturia: Excessive urination at night.
Suprapubic: Situated, occurring, or performed from above the pubis
Dysuria: Painful or difficult urination.


No data regarding the interactions of Flavoxate (HCl) was found.